Morphine is an opioid. It is prescribed for pain severe enough to need an opioid when other treatments are not enough [1]. It is a full opioid agonist, which means there is no ceiling on its pain relief, and the label says the amount is limited instead by adverse reactions, including slowed breathing [1]. It carries the boxed warnings every opioid pain medicine carries: addiction, abuse and misuse that can lead to overdose and death, and breathing that can slow until it stops [1]. It is also the drug the DEA describes as derived from opium [5], and the drug heroin is processed from [12].
This page is the hub for morphine on this site. It covers what the drug is and how it is scheduled, and whether it is addictive. It covers the side effects and the mixes that turn it into an emergency. It covers what an overdose looks like and what naloxone does. It covers withdrawal in outline, how long morphine stays in the body in the only form a federal source supports, and how treatment works. It names no amount and no schedule. Our hub on prescription drug addiction covers the wider class.
The FDA’s label for morphine sulfate tablets describes morphine as a full opioid agonist. It is relatively selective for the mu-opioid receptor, though it can bind to other opioid receptors at higher amounts [1]. Its principal therapeutic action is pain relief. Like all full agonists, it has no ceiling effect for that relief, and the label says the amount a prescriber can give is limited instead by adverse reactions, including respiratory and central nervous system depression [1]. The tablets are indicated for acute pain severe enough to require an opioid, and for chronic pain in adults that is severe enough, where other treatments are inadequate [1]. The label’s own limitation on that use is blunt. Because of the risks of addiction, abuse, misuse, overdose and death, which can occur at any amount or duration, opioids are reserved for patients for whom other options do not work [1].
MedlinePlus puts morphine in the class of opiate analgesics. It relieves severe pain by changing the way the brain and nervous system respond to pain [2]. It lists the forms: an oral solution, an immediate-release tablet, an extended-release tablet, and an extended-release capsule [2]. Its list of brand names marks most of them as no longer on the market, with MS Contin as the one still sold [2]. NIDA describes morphine as a prescription opioid pain reliever used for severe, acute pain, and lists MS Contin, Infumorph, Mitigo and Duramorph as commercial names [4]. The DEA calls it a non-synthetic narcotic with a high potential for abuse, derived from opium, and lists the forms it is sold in: oral solutions, immediate-release and extended-release tablets and capsules, and injectable preparations [5].
The legal status is not in doubt. Morphine sulfate tablets contain morphine, a Schedule II controlled substance [1]. NIDA gives the same schedule [4]. How much is prescribed, how often and for how long are prescriber matters, and none of that is repeated here.
The label answers with its first boxed warning. Morphine exposes users to the risks of addiction, abuse and misuse, which can lead to overdose and death [1]. It tells prescribers to assess each patient’s risk before prescribing and to reassess regularly [1]. The risk of addiction in any individual is unknown, the label says. But it can occur in patients who are prescribed morphine appropriately [1]. In postmarketing studies, addiction, abuse, misuse and fatal and non-fatal overdose were seen in patients with long-term opioid use [1].
The label keeps four terms apart. Misuse is the intentional use of a drug for a medical purpose in a way other than prescribed, or by someone it was not prescribed for [1]. Abuse is the intentional, non-medical use of a drug, even once, for its desirable effects [1]. Addiction is a cluster of behaviors and physical signs. It may include a strong desire to take the drug, trouble controlling use, continuing despite harm, and putting drug use ahead of other obligations [1]. Tolerance is a reduced response after repeated use. Physical dependence is an adaptation that shows itself as withdrawal when the drug is stopped abruptly or cut sharply [1]. The label adds that abuse of opioids can occur without addiction, and that addiction may occur without tolerance or dependence [1]. The label names who is at higher risk: people with a personal or family history of substance abuse, including drug or alcohol abuse or addiction, or of mental illness such as major depression [1].
NIDA lists morphine among the common prescription opioids. It describes how they are misused: taking the medicine in a way or amount other than prescribed, taking someone else’s prescription, or taking it to get high [3]. Sometimes people crush pills, dissolve the powder and inject the liquid, or snort it [3]. The DEA adds that those dependent on morphine prefer injection, because the drug enters the bloodstream more quickly [5]. NIDA’s three definitions line up with the label’s. Long-term use, even as prescribed, can cause some people to develop tolerance. Dependence means the neurons have adapted so they only work normally with the drug present. Addiction is a chronic disease marked by compulsive drug seeking and use despite harmful consequences [3]. MedlinePlus says it to the person taking the drug. Morphine may be habit-forming. Your doctor needs to know if you or anyone in your family has drunk large amounts of alcohol, used street drugs, overused prescription medications, had an overdose, or had depression or another mental illness [2].
Morphine and heroin belong in the same paragraph. NIDA says prescription opioids and heroin are chemically similar and can produce a similar high, and that in some places heroin is cheaper and easier to get, so some people switch [3]. NIDA’s older data put the share of people who misuse prescription opioids and switch to heroin at an estimated 4 to 6 percent, and its more recent data suggest heroin is frequently the first opioid people use [3]. Our hub on heroin addiction covers that drug on its own.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
The common effects are the ones every opioid produces. NIDA lists drowsiness, confusion, nausea, constipation, euphoria and slowed breathing [3]. MedlinePlus adds nausea, vomiting, gas, sweating, headache, weakness and tiredness, and reduced sexual desire or function [2]. The DEA lists relief from pain, less hunger and a suppressed cough reflex [5]. MedlinePlus’s serious list is the one to read twice. Agitation, hallucinations, fever, fast heartbeat, shivering, severe muscle stiffness or twitching and loss of coordination together are a reason to call at once [2]. So are seizures, extreme drowsiness, chest pain or changes in heartbeat, swelling of the face or throat, trouble breathing or swallowing, and unusual snoring or long pauses in breathing during sleep [2].
The label describes what longer use can do. Opioid-induced hyperalgesia is a paradox in which the opioid increases pain, or sensitivity to pain [1]. Opioids can cause sleep-related breathing disorders, including central sleep apnea [1]. Extended use may reduce fertility [1]. MedlinePlus says the breathing risk is highest during the first 24 to 72 hours of treatment and any time the amount is increased. Slowed breathing, long pauses between breaths or shortness of breath call for immediate medical help [2]. If someone is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
The label’s third boxed warning is about mixing. Using an opioid together with benzodiazepines or other central nervous system depressants, including alcohol, may result in profound sedation, respiratory depression, coma and death [1]. Its abuse section adds that misuse raises the risk of overdose, which may lead to central nervous system and respiratory depression, low blood pressure, seizures and death, and that the risk is increased with alcohol and other depressants [1]. MedlinePlus carries two more warnings that belong to morphine’s forms. Extended-release tablets and capsules must be swallowed whole. A broken, chewed, crushed or dissolved one can release too much morphine at once, which may cause serious breathing problems, including overdose and death [2]. And morphine may harm or cause death to other people who take it, especially children, so it is stored where no one else can reach it [2]. The label’s boxed warning says the same: accidental ingestion of even one dose, especially by a child, can be fatal [1].
Two more groups get a sentence each. On pregnancy, the boxed warning says extended use of an opioid during pregnancy can result in neonatal opioid withdrawal syndrome. Unlike withdrawal in adults, it may be life-threatening if not recognized and treated [1]. NIDA adds that pregnant women who seek treatment have better outcomes than those who quit abruptly, and that methadone or buprenorphine treatment during pregnancy improves the chances of a healthier baby at birth [3]. On older adults, NIDA notes a higher risk of accidental misuse, because they typically have multiple prescriptions, chronic diseases and a slower metabolism [3].
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Help for morphine dependence in Florida
The Recovery Village Umatilla is our campus in Umatilla, Florida, and its own page cards medical detox, inpatient treatment for substance abuse, inpatient rehab for mental health, partial hospitalization programming, outpatient programming and aftercare planning. Its aftercare card says the campus outlines each client’s next steps after treatment ends, including follow-up appointments and recommendations for nearby support groups, and where a person starts is decided at the assessment.
See treatment options in Florida Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
The label’s description is direct. Acute overdose with morphine can show as respiratory depression, sleepiness progressing to stupor or coma, limp muscles, cold and clammy skin, and constricted pupils [1]. In some cases there is fluid in the lungs, slow heartbeat, low blood pressure, low blood sugar, airway obstruction, atypical snoring and death [1]. It adds that widened rather than pinpoint pupils may be seen when oxygen is low [1]. MedlinePlus lists the same signs for the person at the bedside: slow, shallow or irregular breathing, difficulty breathing, excessive sleepiness, being unable to respond or wake up, limp or weak muscles, cold and clammy skin, narrowed or widened pupils, and a slow heartbeat [2]. The DEA’s list is cold and clammy skin, lowered blood pressure, sleepiness, slowed breathing, slow pulse, coma and possible death [5].
The response has two halves, and the order matters. NIDA’s instruction is that the most important step is to call 911 so the person can receive immediate medical attention [3]. Naloxone is a medicine that can treat an opioid overdose when given right away, and friends and family can use the nasal spray versions [3]. NIDA’s plain sentence is that too much of an opioid can slow breathing so much that the person suffocates, and that an overdose can be reversed if a reversal medication such as naloxone is given quickly [4]. The label tells prescribers to inform patients and caregivers about reversal agents such as naloxone and nalmefene, and to discuss having one at hand, especially where there are risk factors for overdose or children in the household [1]. It also carries a warning that changes what a bystander should expect. The duration of reversal is expected to be less than the duration of action of morphine. So the person has to be watched until breathing is reliably re-established, and a further dose of the reversal agent may be needed [1]. MedlinePlus says the same thing to the family. Give the first dose of naloxone, call 911 immediately, stay with the person and watch closely until help arrives [2]. Our page on Narcan covers the reversal drug itself.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Withdrawal is what physical dependence looks like when the drug stops. The label says both tolerance and physical dependence can develop during opioid therapy. Dependence may not reach a clinically significant degree until after several days to weeks of continued use [1]. Its instruction to prescribers is firm. Do not rapidly reduce or abruptly discontinue morphine in a patient who is physically dependent [1]. Rapid tapering, the label says, may lead to serious withdrawal symptoms, uncontrolled pain and suicide [1]. When morphine is discontinued, the label calls for a gradual, patient-specific plan. No such plan is on this page.
MedlinePlus lists what withdrawal from morphine feels like: restlessness, teary eyes, runny nose, yawning, irritability, anxiety, sweating, trouble sleeping, chills, back, muscle or joint pain, nausea, vomiting, loss of appetite, diarrhea, stomach cramps, weakness, fast heartbeat and fast breathing [2]. NIDA’s list for morphine is muscle and bone pain, cold flashes with goose bumps, cramps, diarrhea, involuntary leg movements, restlessness, vomiting and insomnia [4]. MedlinePlus’s instruction matches the label’s. If you have been taking morphine regularly, do not stop without talking to your doctor [2].
Two facts from the federal guidance frame the danger correctly. SAMHSA’s detox protocol says that, unlike alcohol and sedative withdrawal, uncomplicated opioid withdrawal is not life-threatening. Rarely, it adds, severe vomiting or diarrhea can lead to dehydration or electrolyte imbalance [7]. The larger risk comes after. MedlinePlus says the biggest complication of opioid withdrawal is returning to the medicine. Most opioid overdose deaths occur in people who have just detoxed. Withdrawal lowers tolerance, so a much smaller amount than before can cause an overdose [6].
This page gives no onset, peak or duration for morphine withdrawal. None of the federal sources cited here publishes a figure for morphine specifically, and figures published for other opioids are not morphine’s. Our page on morphine withdrawal takes the course on its own. Our overview of withdrawal symptoms covers how this compares across substances.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
This is a question people ask about every drug. The honest answer is shorter than the answers found elsewhere.
What the label says. The label reports two half-life figures and says which is which. The effective terminal half-life of morphine after intravenous administration is reported to be approximately 2 hours. In some studies that sampled blood for longer, a longer terminal half-life of about 15 hours was reported [1]. Most of a dose leaves in the urine as two metabolites, and approximately 10 percent is excreted unchanged [1]. A half-life is how long it takes the amount in the blood to fall by half. It is a property of the drug. It is not a detection window, and the two should not be confused.
What the federal tables say. SAMHSA’s table of urine detection periods in TIP 47 has a row for opioids, with codeine and morphine as its examples. Its typical urine detection period is 1 to 3 days [8]. The federal workplace drug-testing rule at 49 CFR 40.85 lists nine analyte groups that laboratories must test for. Codeine and morphine form one of them [9]. SAMHSA’s detox protocol adds the fact that explains a lot of confusion. The usual opioid tests primarily detect the opium-derived drugs, heroin, codeine and morphine, and special tests are ordered for synthetic opioids [7]. The DEA describes heroin as an opiate processed from morphine [12], and SAMHSA’s testing sentence names heroin, codeine and morphine together for that reason: all three derive from opium [7].
What a window depends on. SAMHSA says the time a substance can be detected in urine depends on many interacting factors. It names the drug’s chemical properties such as its half-life, its metabolism and excretion routes, the amount, route, frequency and length of use, the sensitivity and specificity of the assay, and individual variation in health, exercise, diet, weight, gender and fluid intake [8]. So a single number for “how long” is a promise nobody can keep. Our page on how long morphine stays in your system takes the question on its own.
NIDA’s position on opioid addiction is specific. When treating addictions to opioids, medication should be the first line of treatment, usually combined with some form of behavioral therapy or counseling [10]. Methadone, buprenorphine and naltrexone are all FDA-approved medications to treat opioid use disorder. Lofexidine is an FDA-approved medication to reduce opioid withdrawal symptoms [4]. NIDA describes how the three work in one line each. Methadone is a full agonist that activates opioid receptors to ease withdrawal symptoms and cravings. Buprenorphine is a partial agonist that attaches to and partially activates those receptors. Naltrexone is an antagonist that prevents opioids from attaching to their receptors, blocking their effects [3]. Which one, if any, and at what amount is a prescriber’s decision. Our overview of medication-assisted treatment explains how those medicines fit into a longer plan.
Behavioral therapies do the rest of the work. NIDA says they help people modify their attitudes and behaviors related to drug use, handle stress and triggers, and stay in treatment longer [10]. Cognitive-behavioral therapy helps people recognize, avoid and cope with the situations in which they are most likely to use. Contingency management uses rewards for staying drug-free and attending sessions. Motivational enhancement therapy works on readiness to change. Family therapy addresses the influences around a person’s use, especially for young people [10]. Our overview of the types of therapy and our page on cognitive behavioral therapy cover the same ground in more depth.
Detox is where many people start, and it is not where treatment ends. SAMHSA’s protocol says detoxification is not substance abuse treatment and rehabilitation. A detox program is not designed to resolve the longstanding psychological, social and behavioral problems associated with alcohol and drug use [11]. NIDA puts the consequence plainly. Detoxification alone, without subsequent treatment, generally leads to resumption of drug use [10]. MedlinePlus says most people need long-term treatment after detox. It also says anyone going through detox for opioids should be checked for depression and other mental illnesses, because treating those can reduce the risk of relapse [6]. Our page on medical detox explains what makes a detox medical and what has to follow it. Our guide to the levels of care sets out the five treatment levels that come after. Our page on inpatient rehab describes the most structured of them. Our page on outpatient rehab describes the lighter end.
The practical questions settle faster than people expect. Our page on how long rehab takes covers length of stay. Our page on how much rehab costs gives our own published price ranges by level of care. Our guide to insurance coverage covers what a plan decides. Our guide to the admissions process sets out what a program needs before it can give someone a date. Our page on what the rehab process is like walks through a stay. Our treatment center directory has a map you can browse by state.
Yes. The FDA’s label carries a boxed warning that morphine exposes users to the risks of addiction, abuse and misuse, which can lead to overdose and death. It says addiction can occur even in patients who are prescribed it appropriately. Risk is higher with a personal or family history of substance use problems or mental illness. NIDA lists morphine among the prescription opioids whose repeated misuse can lead to an opioid use disorder.
Slow, shallow or irregular breathing, extreme sleepiness progressing to being unable to wake, limp muscles, cold and clammy skin, a slow heartbeat and pinpoint pupils. Call 911 first. Then give naloxone if it is at hand and stay with the person, because the reversal may wear off before the morphine does. If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.
Morphine is a prescription opioid, approved for severe pain and scheduled as Schedule II. Heroin is not used as a medicine in the United States. NIDA says the two are chemically similar and can produce a similar high, and that some people who misuse prescription opioids switch to heroin because it is cheaper and easier to get. The DEA describes heroin as an opiate processed from morphine, and the usual opioid tests detect heroin, codeine and morphine together.
The label reports a terminal half-life of approximately 2 hours after intravenous use in most studies, and about 15 hours in studies that sampled longer. That is a property of the drug and not a test window. SAMHSA’s urine detection table gives a typical period of 1 to 3 days for opioids, with codeine and morphine as its examples. Codeine and morphine form one of the nine analyte groups in the federal workplace testing rule.
Methadone, buprenorphine and naltrexone are FDA-approved to treat opioid use disorder, and lofexidine is approved to reduce withdrawal symptoms. NIDA says medication should be the first line of treatment for opioid addiction, usually with behavioral therapy. Methadone activates opioid receptors, buprenorphine partially activates them, and naltrexone blocks them. Which one fits, and at what amount, is a prescriber’s decision.
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Get cost-effective, quality addiction care that truly works.
Start Your Recovery